Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein thiols and cellular nucleophilic residues are reactive chemical groups, predominantly the sulfhydryl (-SH) groups of cysteine and the amino groups of lysine, that serve as critical sites for biological regulation and pharmacological intervention. These residues play a fundamental role in maintaining cellular redox homeostasis and participating in signal transduction through reversible post-translational modifications such as S-glutathionylation and S-nitrosylation (Source: NIH/NCBI). In a therapeutic context, they are the primary targets for electrophilic drugs, including many classical chemotherapeutic alkylating agents and modern covalent inhibitors, which form irreversible bonds to modulate protein activity (Source: PubMed). Because these nucleophilic sites are ubiquitous throughout the proteome, drugs targeting them often face challenges related to specificity and systemic toxicity (Source: Nature Reviews Drug Discovery). Furthermore, the modification of these residues can lead to the formation of haptens, potentially triggering adverse immune responses or idiosyncratic drug reactions (Source: PubChem). They are also essential components of the cellular antioxidant defense system, with glutathione being the most prominent non-protein thiol involved in detoxifying reactive oxygen species (Source: StatPearls). Despite the risks of off-target effects, the strategic targeting of specific nucleophilic residues has led to the development of highly effective therapies for cancer and autoimmune disorders. Overall, they represent a broad but essential landscape of chemical reactivity within the cell that dictates both health and disease states.
Covalent modification of nucleophilic sites via alkylation, arylation, or Michael addition, leading to protein inactivation, altered signaling, or DNA cross-linking.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein thiols and cellular nucleophilic residues.